Fertility and Sterility
Volume 94, Issue 5 , Pages 1775-1781 , October 2010

The cohort of antral follicles measuring 2–6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation

This article was presented orally at the 25th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) held at Amsterdam, the Netherlands (June 28 to July 1, 2009).

Received 26 June 2009 ,Revised 8 October 2009 ,Accepted 13 October 2009.

References 

  1. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–3071
  2. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291–301
  3. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718
  4. Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2008;Nov. 29 [Epub ahead of print]
  5. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–714
  6. Penarrubia J, Fabregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment. Hum Reprod. 2005;20:915–922
  7. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS. Anti-Mullerian hormone (AMH): what do we still need to know?. Hum Reprod. 2009;24:2264–2275
  8. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77:328–336
  9. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril. 1998;69:505–510
  10. Nahum R, Shifren JL, Chang Y, Leykin L, Isaacson K, Toth TL. Antral follicle assessment as a tool for predicting outcome in IVF—is it a better predictor than age and FSH?. J Assist Reprod Genet. 2001;18:151–155
  11. Haadsma ML, Bukman A, Groen H, Roeloffzen EM, Groenewoud ER, Heineman MJ, et al. The number of small antral follicles (2–6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod. 2007;22:1925–1931
  12. Sharara FI, McClammrock HD. Antral follicle count and ovarian volume predict IVF outcome. Fertil Steril. 2000;74:S176
  13. Hsieh YY, Chang CC, Tsai HD. Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation. J Assist Reprod Genet. 2001;18:320–324
  14. Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril. 2003;80:350–355
  15. Raine-Fenning NJ, Lam PM. Assessment of ovarian reserve using the inversion mode. Ultrasound Obstet Gynecol. 2006;27:104–106
  16. Jayaprakasan K, Walker KF, Clewes JS, Johnson IR, Raine-Fenning NJ. The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques. Ultrasound Obstet Gynecol. 2007;29:335–341
  17. Jayaprakasan K, Hilwah N, Kendall NR, Hopkisson JF, Campbell BK, Johnson IR, et al. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment?. Hum Reprod. 2007;22:1932–1941
  18. Raine-Fenning N, Jayaprakasan K, Clewes J, Joergner I, Bonaki SD, Chamberlain S, et al. SonoAVC: a novel method of automatic volume calculation. Ultrasound Obstet Gynecol. 2008;31:691–696
  19. Raine-Fenning N, Jayaprakasan K, Chamberlain S, Devlin L, Priddle H, Johnson I. Automated measurements of follicle diameter: a chance to standardize?. Fertil Steril. 2009;91:1469–1472
  20. Deb S, Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC. Ultrasound Obstet Gynecol. 2009;33:477–483
  21. Raine-Fenning NJ, Campbell BK, Clewes JS, Kendall NR, Johnson IR. The reliability of virtual organ computer-aided analysis (VOCAL) for the semiquantification of ovarian, endometrial and subendometrial perfusion. Ultrasound Obstet Gynecol. 2003;22:633–639
  22. Deb S, Batcha M, Campbell BK, Jayaprakasan K, Clewes JS, Hopkisson JF, et al. The predictive value of the automated quantification of the number and size of small antral follicles in women undergoing ART. Hum Reprod. 2009;24:2129–2132
  23. Raine-Fenning N, Jayaprakasan K, Clewes J. Automated follicle tracking facilitates standardization and may improve work flow. Ultrasound Obstet Gynecol. 2007;30:1015–1018
  24. NICE. Fertility: assessment and treatment for people with fertility problems. London: National collaborating centre for Women's and Children's Health for the National Institute for Clinical Excellence, RCOG Press; 2004;33
  25. Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, te Velde ER. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril. 2003;79:1091–1100
  26. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77–83
  27. Andersen CY, Byskov AG. Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid. J Clin Endocrinol Metab. 2006;91:4064–4069
  28. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?. Bjog. 2004;111:1248–1253
  29. La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22:766–771
  30. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867–875
  31. Haadsma ML, Groen H, Fidler V, Seinen LH, Broekmans FJ, Heineman MJ, et al. The predictive value of ovarian reserve tests for miscarriage in a population of subfertile ovulatory women. Hum Reprod. 2009;24:546–552
  32. Luca X, Martinez EA, Roca J, Vazquez JM, Gil MA, Pastor LM, et al. Relationship between antral follicle size, oocyte diameters and nuclear maturation of immature oocytes in pigs. Theriogenology. 2002;58:871–885
  33. Khairy M, Clough A, El-Toukhy T, Coomarasamy A, Khalaf Y. Antral follicle count at down-regulation and prediction of poor ovarian response. Reprod Biomed Online. 2008;17:508–514
  34. Grynberg M, Feyereisen E, Scheffer JB, Koutroubis P, Frydman R, Fanchin R. Early follicle development alters the relationship between antral follicle counts and inhibin B and follicle-stimulating hormone levels on cycle day 3. Fertil Steril. 2008;Dec 3 [Epub ahead of print]
  35. Hillier SG, Miro F, Inhibin , activin , follistatin . Potential roles in ovarian physiology. Ann N Y Acad Sci. 1993;687:29–38
  36. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996;81:1401–1405
  37. Mais V, Cetel NS, Muse KN, Quigley ME, Reid RL, Yen SS. Hormonal dynamics during luteal-follicular transition. J Clin Endocrinol Metab. 1987;64:1109–1114
  38. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab. 1995;80:3537–3545

 K.J. has nothing to disclose. S.D. has nothing to disclose. M.B. has nothing to disclose. J.H. has nothing to disclose. I.J. has nothing to disclose. B.C. has nothing to disclose. N.R.-F. has nothing to disclose.

PII: S0015-0282(09)03884-9

doi: 10.1016/j.fertnstert.2009.10.022

Fertility and Sterility
Volume 94, Issue 5 , Pages 1775-1781 , October 2010

Article Tools

* Image Usage & Resolution